Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn about a recent article by Wei Liu et al, published in Signal Transduction and Targeted Therapy:
”New Haemophilia A phase 1 gene therapy study from China.
Used AAV8 with BDD FVIII.
Two cohorts: 2e12 and 4e12.
Prophylactic steroids +/- tacrolimus.
FVIII:C at 144 weeks of 2e12 was 5.6 iu/dl.
FVIII:C at 104 weeks of 4e12 was 42.7 iu/dl.
As with other AAV FVIII gene therapies, FVIII:C falls with time, chromogenic > 1-stage FVIII, and there is significant variation in achieved FVIII levels between patients.”
Title: Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity
Authors: Wei Liu, Xiaolei Pei, Tenghui Yu, Bingqi Xu, Xinyue Dai, Feng Xue, Lingling Chen, Xiaolin Wang, Yuhua Wang, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Wentian Wang, Ying Chi, Hui yuan Li, Renchi Yang, Lei Zhang
Read the Full Article on Nature: Signal Transduction and Targeted Therapy

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation